Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Carlo Basile
One-Size-Does-Not-Fit-All: The Case of Incremental Hemodialysis
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney Failure
Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney Failure Maria Jose Soler, Marlies Noordzij, Daniel Abramowicz, Gabriel de Arriba, Carlo Basile, Marjolijn van Buren, Adrian Covic, Marta Crespo, Raphael Duivenvoorden, Ziad Massy, Alberto Ortiz, Emilio Sanchez, Emily Petridou, Kathryn Stevens, Colin White, Priya Vart, Ronald Gansevoort CJASN Jun 2021, CJN.18961220; DOI: 10.2215/CJN.18961220
The Long-Term Safety of Dialysate Citrate
The bicarbonate-based dialysate contains a few millimoles of acetic acid to stabilize the pH. Due to the favourable dialysate–plasma gradient, the plasma acetate levels at the end of the haemodialysis (HD) session are several times higher than pre-treatment, such as to induce the well-known acetate adverse effects.[1] Citric acid is an alternative dialysate buffer that is converted to its anion citrate into the body.
Frontiers in haemodialysis: Innovations and technological advances
THOUGHTS & PROGRESS Dimitrios Kirmizis Corresponding Author E-mail address: dkirmizis@yahoo.co.uk https://orcid.org/0000-0002-5093-1570 Department of Nephrology, Colchester General Hospital, Essex, U.K Corresponding author: Dr. Dimitrios Kirmizis Department of Nephrology, Colchester General Hospital, Turner Road, Mile End, Colchester, CO4 5JL, United Kingdom Email: dkirmizis@yahoo.co.uk Search for more papers by this author This article has been accepted for publication and undergone full...
Vascular Access: 2018 Clinical Practice Guidelines of the European Society Vascular Surgery (ESVS)
Article in Press Vascular Access: 2018 Clinical Practice Guidelines of the European Society Vascular Surgery (ESVS)☆, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Publication HistoryPublished online: May 02, 2018 ☆The ESVS guidelines for Vascular Access are endorsed by the Vascular Access Society (VAS).aWriting Group: Jürg Schmidli∗ (Bern, Switzerland), Matthias K.
The variable target model: a paradigm shift in the incremental haemodialysis prescription
Background The recent interest in incremental haemodialysis (HD) is hindered by the current prescription based on a fixed target model (FTM) for the total (dialytic + renal) equivalent continuous clearance (ECC). The latter is expressed either as standard Kt/V (stdKt/V), i.e. the pre-dialysis averaged concentration of urea-based ECC, or EKRc, i.e. the time averaged concentration-based ECC, corrected for volume (V) = 40 L.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Carlo
Contact Carlo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack